Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 8 to 10 amino acid residues in defined sequence
Reexamination Certificate
2007-08-30
2010-02-23
Rawlings, Stephen L (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
8 to 10 amino acid residues in defined sequence
Reexamination Certificate
active
07666984
ABSTRACT:
The invention relates to a tumor-associated peptide containing an amino sequence, which is selected from the group consisting of SEQ ID NO:1 to SEQ ID NO:79 of the enclosed listing. The peptide has the ability to bind to a molecule of the human major histocompatibility complex (MHC) class-I. The invention also relates to the use of the peptides for manufacture of a medicament and for treating tumorous diseases. The invention further relates to a pharmaceutical composition, which comprises at least one of the peptides.
REFERENCES:
patent: 4810781 (1989-03-01), Hollinshead
patent: 6809179 (2004-10-01), Konopitzky et al.
patent: 2002/0007173 (2002-01-01), Kundig et al.
patent: 19936563 (2001-08-01), None
patent: WO 02/50103 (2002-06-01), None
patent: WO 02/094981 (2002-11-01), None
Nagase et al (DNA Res., 4:141-150, 1997).
Nagase, T. et al.: “Human MRNA for KIAA0367 Gene, Partial CDS,” Genbank, Database Online, Oct. 4, 2005; pp. 1-3.
Parker et al; Scheme for Ranking Potential . . . Peptide Side-Chains, Journal of Immunology; XP-00088437; 1994; pp. 163-175.
Park et al., Sequence of MET protooncogene cDNA . . . receptors; Proc. Natl. Acad. Sci. USA; XP-000941506; 1978; pp. 6379-6383.
Heid et al.; Adipocyte differentiation-related . . . membrane; Biochem J.; XP-002060680; 1996, pp. 1025-1030.
Weinschenk et a l.; Integrated Functional . . . Antitumor Vaccines; Cancer Research, vol. 62; Oct. 15, 2002; pp. 5818-5827.
Schirle et al.; Identification of tumor-associated . . . approach; Eur. J. Immunol., vol. 30, XP-002246625; 2000; pp. 2216-2225.
Schmidt et al.; Induction of Adipophilin-Specific . . . Cell Lysis; Cancer Research, vol. 64, Feb. 1, 2004; pp. 1164-1170.
Renner et al. An. Hematol. 80: 255-266; 2001.
Schirle et al., Eur. J. Immunol. (2000) 30:2216-2225.
Rammensee Hans Georg
Stevanovic Stefan
Weinschenk Toni
Baker Donelson Bearman, Caldwell & Berkowitz, P.C.
Duffy Brad
Immatics Biotechnologies GmbH
Rawlings Stephen L
LandOfFree
Tumour-associated peptides binding to MHC-molecules does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tumour-associated peptides binding to MHC-molecules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumour-associated peptides binding to MHC-molecules will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4196910